The antiepileptic drug zonisamide inhibits MAO-B and attenuates MPTP toxicity in mice: Clinical relevance-Reference-Cited by-同舟云学术

The antiepileptic drug zonisamide inhibits MAO-B and attenuates MPTP toxicity in mice: Clinical relevance

Published:2010-02 Issue:2 Volume:221 Page:329-334
ISSN:0014-4886
Container-title:Experimental Neurology
language:en
Short-container-title:Experimental Neurology

Author:

Sonsalla Patricia K.,Wong Lai-Yoong,Winnik Bozena,Buckley Brian

Publisher

Elsevier BV

Subject

Developmental Neuroscience,Neurology

Reference34 articles.

1. Adenosinergic protection of dopaminergic and GABAergic neurons against mitochondrial inhibition through receptors located in the substantia nigra and striatum, respectively;Alfinito;J. Neurosci.,2003

2. Protective effects of a novel anti-parkinsonian agent zonisamide on dopamine quinone-related neurotoxicity;Asanuma;Society for Neuroscience Program Nol,2007

3. Preventing effects of a novel anti-parkinsonian agent zonisamide on dopamine quinone formation;Asanuma;Neurosci. Res.,2008

4. Clinical pharmacology and mechanism of action of zonisamide;Biton;Clin. Neuropharmacol.,2007

5. Interactions between two enantiomers of losigamone and conventional antiepileptic drugs in the mouse maximal electroshock model—an isobolographic analysis;Borowicz;Eur. J. Pharmacol.,2007

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Results from a randomized controlled trial of zonisamide in the treatment of alcohol use disorder;Journal of Psychiatric Research;2024-09

2. Modulating Endoplasmic Reticulum Chaperones and Mutant Protein Degradation in GABRG2(Q390X) Associated with Genetic Epilepsy with Febrile Seizures Plus and Dravet Syndrome;International Journal of Molecular Sciences;2024-04-23

3. Behavioral effects of zonisamide on L-DOPA-induced dyskinesia in Parkinson's disease model mice;Frontiers in Aging Neuroscience;2023-06-27

4. Physiological changes in advanced Parkinson's disease: Altered motor cortical plasticity and its significance in pathophysiology and clinical symptoms;Neurology and Clinical Neuroscience;2023-05-12

5. Behavioral effects of zonisamide on L-DOPA-induced dyskinesia in Parkinson’s disease model mice;2023-05-01